Jones Financial Companies
XENE icon

Jones Financial Companies’s Xenon Pharmaceuticals XENE Stock Holding History

Jones Financial Companies’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$195K Buy
3,268
+869
+36% +$48.2K ﹤0.01% 2588
2026
Q1 		$131K Buy
2,399
+2,249
+1,499% +$104K ﹤0.01% 2557
2025
Q4 		$6.72K Buy
+150
New +$6.3K ﹤0.01% 3390

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Jones Financial Companies's XENE Position: Q2 2026 in Review

Jones Financial Companies increased its Xenon Pharmaceuticals (XENE) stake by 36% in Q2 2026, buying an estimated $48.2K and bringing the position to 3,268 shares worth $195K. The position accounts for ﹤0.01% of the portfolio, ranked #2588.

Jones Financial Companies first reported a position in XENE in Q4 2025 and has held it in 3 quarters since. 315 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

  • Jones Financial Companies held 3,268 shares of Xenon Pharmaceuticals worth $195K as of Q2 2026.
  • Jones Financial Companies bought 869 Xenon Pharmaceuticals shares in Q2 2026, an estimated $48.2K.
  • Xenon Pharmaceuticals made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #2588 holding.
  • Jones Financial Companies first reported a position in Xenon Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 315 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.